期刊文献+

不同年龄胃癌患者临床病理特征及预后分析 被引量:5

下载PDF
导出
摘要 目的探讨不同年龄胃癌患者的临床病理特征及其预后相关因素。方法以在我院住院手术治疗的185例老年胃癌患者和157例中青年胃癌患者作为研究对象,比较两组患者的临床症状、病理特征及预后等相关资料。结果老年组患者上腹部不规律疼痛的比例少于中青年组(P<0.01);老年组出现消瘦的比例多于中青年组(P<0.01)。老年组胃癌Borrmann分型以Ⅲ型为主,浸润程度以T3为主,病例分型以腺癌为主;老年组低分化比例及远端转移比例低于中青年组(P<0.01);老年组患者1年期生存率、3年期生存率和5年生存率均高于中青年组(P<0.05或P<0.01)。结论不同年龄胃癌患者,均需要引起足够的重视。针对不同特点,提高诊断率,积极治疗以改善预后。
出处 《白求恩医学杂志》 2015年第6期638-639,共2页 Journal of Bethune Medical Science
  • 相关文献

参考文献6

二级参考文献25

  • 1施春雷,韩宝惠.ASCO不可手术切除的非小细胞肺癌治疗指南——2003新版推荐指南[J].循证医学,2004,4(2):115-124. 被引量:114
  • 2Sobin LH, Gospodarowicz MK, Wittekind C.International Union Against Cancer (UICC) TNM classification of malignant tumours.7th ed.New York:Wiley- Liss,2010.
  • 3Ichikura T,Tomimatsu S,Okusa Y,et al.Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer.J Clin Oncol,1993,11(10):1894-1900.
  • 4Huang B,Zheng X,Wang Z,et al.Prognostic significance of the number of metastatic lymph nodes:is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol,2009,16(1):61 -67.
  • 5Deng J,Liang H,Sun D,et al.Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China.Ann Surg Oncol,2010,17(5):1259-1266.
  • 6Li C,Oh SJ,Kim S,et al.Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.Oncology,2009,77(3-4):197-204.
  • 7Chiou WL, Jeong HY, Wu TC, et al. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity [ J].Clin Pharmacol Ther, 2001,70: 305-310.
  • 8Yamamato N, Tamura T, Kamiya Y, et al. Correlation Between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of Exogenous cortisol [ J ]. J Clin Oncol, 2000,18 ( 11 ):2 301 -2 308.
  • 9Tateishi T, Watanabe M, Nakura H, et al. CYP3A activity in European American and Japanese men using midazolam as an in vivo probe[J]. Clin Pharmacol Ther, 2001,69: 333-338.
  • 10Gorski JC, Jones DR, Haehner-Daniels BD, et al. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin[ J]. Clin Pharmacol Ther, 1998,64: 133 -143.

共引文献110

同被引文献51

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部